Zim Laboratories Ltd. (ZIMLAB)
MSE MSE Primary XNSE Summary
ZIMLAB Chart
People also search for
Zim Laboratories Ltd. (ZIMLAB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Zim Laboratories Ltd. ever had a stock split?
Zim Laboratories Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Chandrashekhar Mainde CEO | MSE Exchange | INE518E01015 ISIN |
| India Country | 577 Employees | 18 Jan 2022 Last Dividend | 22 Dec 2022 Last Split | - IPO Date |
Overview
ZIM Laboratories Limited is a prominent player in the pharmaceutical and nutraceutical industry, operating both in India and on an international scale. Since its establishment in 1984, the company has dedicated itself to the development, manufacturing, and supply of generic pharmaceutical products alongside nutraceutical items. With a base in Nagpur, India, ZIM Laboratories has carved a niche for itself by specializing in the production of a wide array of oral solid dosage forms. They're known for utilizing modified release patterns to enhance the effectiveness and patient compliance of their products.
Products and Services
ZIM Laboratories Limited offers an extensive range of products and services designed to cater to various therapeutic areas, utilizing advanced technology and innovative delivery systems. Their product offerings include:
- Pre-formulation Intermediates: These are critical components in the development of pharmaceutical formulations, enabling the creation of effective, stable, and high-quality medications.
- Finished Formulations: ZIM Laboratories produces finished pharmaceutical formulations in various delivery forms, such as tablets, capsules, and more, with a focus on ensuring optimal drug release patterns.
- Modified Release Oral Solid Dosage Forms: Specializing in modified release technologies, the company produces granules, pellets, taste-masked powders, suspensions, tablets, and capsules that offer controlled or extended drug release to improve patient compliance and efficacy.
- Oral Thin Films: A cutting-edge product line offering a novel way of drug delivery through dissolvable films, which provides an alternative for patients who have difficulty swallowing pills.
- Dry Syrup: Another form of oral medication, dry syrup requires addition of water at the time of administration, making it a versatile and preferable option for certain medicines, particularly for pediatric use.
- Therapeutics: The company’s therapeutic range covers several areas such as urology, gastroenterology, CNS (central nervous system), antibiotics, anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements, addressing a broad spectrum of healthcare needs.
